ING3 and ING4 immunoexpression and their relation to the development of benign odontogenic lesions
Authors:
- Yailit del Carmen Martinez-VargasYMYailit del Carmen Martinez-Vargas
- Tiago João da Silva-FilhoTSTiago João da Silva-Filho
- Denise Hélen Imaculada Pereira de OliveiraDODenise Hélen Imaculada Pereira de Oliveira
- Rani Iani Costa GonçaloRGRani Iani Costa Gonçalo
- Lélia Maria Guedes QueirozLQLélia Maria Guedes Queiroz
Open Access
- 1 August 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Dental Journal
- Vol. 32 (4) , 74-82
Abstract
The Inhibitor of Growth (ING) gene family is a group of tumor suppressor genes that play important roles in cell cycle control, senescence, DNA repair, cell proliferation, and apoptosis. However, inactivation and downregulation of these proteins have been related in some neoplasms. The present study aimed to evaluate the immunohistochemical profiles of ING3 and ING4 proteins in a series of benign epithelial odontogenic lesions. Methods: The sample comprised of 20 odontogenic keratocysts (OKC), 20 ameloblastomas (AM), and 15 adenomatoid odontogenic tumors (AOT) specimens. Nuclear and cytoplasmic immunolabeling of ING3 and ING4 were semi-quantitatively evaluated in epithelial cells of the odontogenic lesions, according to the percentage of immunolabelled cells in each case. Descriptive and statistics analysis were computed, and the p-value was set at 0.05. Results: No statistically significant differences were found in cytoplasmic and nuclear ING3 immunolabeling among the studied lesions. In contrast, AOTs presented higher cytoplasmic and nuclear ING4 labeling compared to AMs (cytoplasmic p-value = 0.01; nuclear p-value < 0.001) and OKCs (nuclear p-value = 0.007). Conclusion: ING3 and ING4 protein downregulation may play an important role in the initiation and progression of more aggressive odontogenic lesions, such as AMs and OKCs.Keywords
This publication has 23 references indexed in Scilit:
- Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancerHuman Pathology, 2011
- The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI‐1 and bcl‐2 is similar to ameloblastoma but different from odontogenic cystsJournal of Oral Pathology & Medicine, 2009
- Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14Melanoma Research, 2009
- Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous MelanomaClinical Cancer Research, 2007
- Detection of novel mRNA splice variants of human ING4 tumor suppressor geneOncogene, 2007
- Function of the ING family of PHD proteins in cancerThe International Journal of Biochemistry & Cell Biology, 2005
- Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid adontogenic tumorBrazilian Dental Journal, 2005
- HuntING4 New Tumor SuppressorsCell Cycle, 2005
- p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomasJournal of Oral Pathology & Medicine, 2004
- Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancersOncogene, 2002